KEAP1 and cancer: In cancer, loss of KEAP1 function leads to enhanced activity of NRF2 and antioxidant-related element (ARE)-driven gene expression, thus promoting cellular resistance to oxidative stress, rapid proliferation, and metabolic deregulation [9].